Dyne Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC DYN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

214,491

Value ($000)

4,195

Weight

0.0%

2021 Q3 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,195	0.0%	214,491	12/31/2025
2025 Q3	11/14/2025	2,902	0.0%	229,430	9/30/2025
2025 Q2	8/14/2025	2,795	0.0%	293,644	6/30/2025
2025 Q1	5/19/2025	1,650	0.0%	157,791	3/31/2025
2024 Q4	2/14/2025	3,378	0.0%	143,363	12/31/2024
2024 Q3	11/14/2024	4,825	0.0%	134,334	9/30/2024
2024 Q2	8/14/2024	4,501	0.0%	127,550	6/30/2024
2024 Q1	5/15/2024	888	0.0%	31,281	3/31/2024
2023 Q4	2/14/2024	338	0.0%	25,389	12/31/2023
2023 Q3	11/13/2023	110	0.0%	12,222	9/30/2023
2023 Q2	8/11/2023	141	0.0%	12,222	6/30/2023
2023 Q1	5/15/2023	141	0.0%	12,222	3/31/2023
2022 Q4	2/14/2023	142	0.0%	12,222	12/31/2022
2022 Q3	11/14/2022	155	0.0%	12,222	9/30/2022
2022 Q2	8/12/2022	84	0.0%	12,222	6/30/2022
2022 Q1	5/16/2022	118	0.0%	12,222	3/31/2022
2021 Q4	2/14/2022	145	0.0%	12,222	12/31/2021
2021 Q3	11/15/2021	198	0.0%	12,222	9/30/2021